TCI Wealth Advisors’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-7
Closed -$1K 2513
2022
Q3
$1K Buy
+7
New +$996 ﹤0.01% 2049
2022
Q1
Sell
-15
Closed -$10K 2251
2021
Q4
$10K Buy
15
+6
+67% +$4.59K ﹤0.01% 1145
2021
Q3
$8K Buy
9
+4
+80% +$4.06K ﹤0.01% 1231
2021
Q2
$6K Hold
5
﹤0.01% 1286
2021
Q1
$6K Buy
+5
New +$6.6K ﹤0.01% 1126
2019
Q4
Sell
-2
Closed -$1K 1543
2019
Q3
$1K Hold
2
﹤0.01% 1240
2019
Q2
$1K Buy
+2
New +$400 ﹤0.01% 1157

Other funds holding CDLX

TCI Wealth Advisors's CDLX Position: Q4 2022 in Review

TCI Wealth Advisors sold out of Cardlytics (CDLX) in Q4 2022, closing a stake of 7 shares — an estimated $1K sold.

TCI Wealth Advisors first reported a position in CDLX in Q2 2019 and held it in 7 quarters. The position peaked at $10K in Q4 2021. 121 funds tracked by Wall St. Rank hold CDLX as of Q4 2022.

  • TCI Wealth Advisors reported no remaining Cardlytics position as of Q4 2022 after selling out during the quarter.
  • TCI Wealth Advisors sold 7 Cardlytics shares in Q4 2022, an estimated $1K.
  • TCI Wealth Advisors first reported a position in Cardlytics in Q2 2019 and held it in 7 quarters.
  • TCI Wealth Advisors's Cardlytics position peaked at $10K in Q4 2021.
  • 121 funds tracked by Wall St. Rank held Cardlytics as of Q4 2022.

Based on TCI Wealth Advisors's 13F filing for Q4 2022, filed 7 Feb 2023.